Skip to main content
. 2018 Feb 2;32(7):1561–1566. doi: 10.1038/s41375-018-0017-0

Fig. 2.

Fig. 2

a Event-free survival by genomic HRD-LOH. Kaplan–Meier plots demonstrating the probability of survival for those patients with genomic HRD-LOH <5% (n = 150, median 0.512 years) vs. ≥5% (n = 65, median 0.197 years). Hazard ratio 1.79 (1.3, 2.5); p = 0.00065. b Overall survival by genomic HRD-LOH. Kaplan–Meier plots demonstrating the probability of survival for those patients with genomic HRD-LOH <5% (n = 150, median 1.266 years) vs. ≥5% (n = 65, median 0.939 years). Hazard ratio 2.18 (1.5, 3.2); p = 8.23e−05